Craig Blackstone

Scientific Advisor, Neuro at NKGen Biotech

Dr. Craig Blackstone is Chief of the Movement Disorders Division at the Massachusetts General Hospital and Professor of Neurology at Harvard Medical School. Previously, he was a Senior Investigator in the Intramural Research Program of the National Institute of Neurological Disorders and Stroke for nearly two decades. His research group investigates the cellular and molecular mechanisms underlying hereditary movement disorders.

Dr. Blackstone has published ~170 research and review articles and has presented ~180 invited lectures throughout the world. He is an elected member of the American Society for Clinical Investigation and Association of American Physicians, as well as an elected Fellow and former Vice President of the American Neurological Association (ANA). He has held numerous other leadership positions in the ANA, including on its Executive Council, Education Innovation Committee, Nominations Committee, Professional Development Committee, Translational and Clinical Research Course Committee, Web Governance Committee, and Research Careers Reimagined Subcommittee. He has served for well over a decade on the editorial board of the prestigious Journal of Clinical Investigation.

Dr. Blackstone received the NIH Director’s Ruth L. Kirschstein Mentoring Award in 2012 and the NINDS Director’s Diversity Achievement Award in 2018. In 2022, he was elected to the National Academy of Medicine, the pinnacle of recognition for outstanding achievement in the medical sciences.

Dr. Blackstone completed his neurology residency at Brigham and Women’s Hospital and a fellowship in clinical neurology at Massachusetts General Hospital. He obtained his MD and PhD degrees in Medicine and Neuroscience from The Johns Hopkins University School of Medicine.

Timeline

  • Scientific Advisor, Neuro

    Current role